Stock comparison
Cellebrite DI
KLA
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
CLBT
Cellebrite DI
Market cap
$3.29B
Sector
Technology
KLAC
KLA
Market cap
$246.68B
Sector
Technology
Overall winner
KLA KLAC
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | CLBT | KLAC | Winner |
|---|---|---|---|
| Warren Buffett | 48D | 80A | KLAC |
| Benjamin Graham | 62D | 94A | KLAC |
| Philip Fisher | 60C | 90A | KLAC |
| Peter Lynch | 34F | 78B | KLAC |
| Joel Greenblatt | 51C | 78C | KLAC |
| Charlie Munger | 49D | 93A | KLAC |
| Terry Smith | 50D | 94A | KLAC |
Side-by-side metrics
| Metric | CLBT | KLAC |
|---|---|---|
| Market cap | $3.29B | $246.68B |
| P/E (TTM) | 44.5x | 51.8x |
| EV/EBIT | 47.7x | 46.9x |
| ROIC (TTM) | 10.02% | 36.29% |
| Gross margin | 84.2% | 61.75% |
| Net margin | 16.47% | 35.66% |
| Revenue CAGR 5y | 17.89% | 15.13% |
| EPS CAGR 5y | -10.56% | 22.65% |
| Debt / Equity | 0.0x | 1.1x |
| Dividend yield | 0.0% | 0.43% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CLBT leads on
- Debt / Equity0.0xvs 1.1x+96%
- Gross margin84.2%vs 61.75%+27%
- Revenue CAGR 5y17.89%vs 15.13%+15%
- P/E (TTM)44.5xvs 51.8x+14%
KLAC leads on
- EPS CAGR 5y22.65%vs -10.56%+147%
- Dividend yield0.43%vs 0.0%+100%
- Market cap$246.68Bvs $3.29B+99%
- ROIC (TTM)36.29%vs 10.02%+72%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.